Clinical Trials Logo

Clinical Trial Summary

A phase II random, double blind, positive and placebo control trail was conducted in 1200 healthy women in the arm A: 18-26 years old and 600 healthy women in the Arm B: 27-45 years old. The 1800 subjects to be inoculated with middle, and high dose vaccine. Middle dose SCT1000: hight dose SCT1000: placebo: positive control =1:1:1:1.Two arms can be recruited at the same time. If the DSMB assessment shows that the adverse events of a certain dose group meet the criteria of suspension / termination, the dose group will be suspended / terminated.


Clinical Trial Description

Arm A: 18-26 years old. Random, double blind, Gardasil®9 positive control and placebo control was conducted in 1200 healthy women. Middle dose SCT1000: hight dose SCT1000: placebo: positive control =1:1:1:1.Arm B: 27-45 years old. Random, double blind, Gardasil® positive control and placebo control was conducted in 600 healthy women. Middle dose SCT1000: hight dose SCT1000: placebo: positive control =1:1:1:1.Two arms can be recruited at the same time. If the DSMB assessment shows that the adverse events of a certain dose group meet the criteria of suspension / termination, the dose group will be suspended / terminated, and the study of other dose groups will continue. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05060484
Study type Interventional
Source Sinocelltech Ltd.
Contact Fengcai Zhu, Master
Phone 8625-83759984
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date October 8, 2021
Completion date July 31, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Terminated NCT01395238 - Enhancing Father's Ability to Support Their Preschool Child N/A
Completed NCT00589173 - An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care N/A
Completed NCT00535665 - Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine Phase 2
Completed NCT00995462 - Prevention of Weight Gain in University Students N/A
Completed NCT00814554 - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers N/A
Completed NCT00966212 - Parent Education for Young Teen Females Phase 2/Phase 3
Completed NCT04526873 - Encouraging Annual Wellness Visits Among ACO Beneficiaries N/A
Not yet recruiting NCT05090241 - Frailty Prevention in Elders From Reunion Island
Completed NCT04032145 - Characterization of Health Conditions of Visitors of the Montreal Museum of Fine Arts
Completed NCT04785599 - Lymphedema Prevention After Lymph Node Emptying N/A
Recruiting NCT01021488 - Rosuvastatin for Preventing Deep Vein Thrombosis Phase 4
Terminated NCT02247258 - Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. Phase 2
Completed NCT04162977 - Adapting Personality-Targeted Interventions for Reducing Substance Misuse and Related Outcomes in Youth in Youth Protection Services N/A
Terminated NCT03192514 - Electronic Deprescribing Tool for the Prevention of PIP N/A
Enrolling by invitation NCT04003675 - Sexual Harassment Within and Outside Sports
Completed NCT04094233 - Acute Effects of Beet Extract on Autonomic and Cardiovascular Recovery After Exercise N/A
Completed NCT01828567 - Will Veterans Engage in Prevention After HRA-guided Shared Decision Making? N/A
Recruiting NCT03281343 - Linking Women to PrEP Care N/A
Active, not recruiting NCT01924247 - Study to Validate the Effects of an Outpatient Secondary Prevention Program for Stroke Victims N/A